Board Member Profile

  1. Top
  2. Business area
  3. Board Member Profile



(Date of birth: Oct. 13, 1960)


Apr. 1985Joined Fuji Photo Film Co., Ltd. (currently FUJIFILM Corp.(FUJIFILM))
Oct. 1996Manager, Ashigara Research Laboratories, FUJIFILM
Apr. 2004Senior manager, Research and Development Management HQ, Digital & Photo Imaging Material Research Laboratories, FUJIFILM
Jun. 2007Deputy General Manager, life science Research Laboratories, Research and Development Management HQ / Senior Manager, Business Development Office Life Science Business Division, FUJIFILM
Jul. 2008Toyama Chemical Co., Ltd. (currently FUJIFILM Toyama Chemical Co., Ltd.) on loan
Jun. 2009General Manager, Drug Discovery Research Laboratories, Research and Development Management HQ, FUJIFILM
Sep. 2013General Manager, Regenerative Medicine Business Development Office/Deputy General Manager, Pharmaceutical Products. Div., FUJIFILM
Apr. 2015Manager, Regenerative Medicine Business Development Office, FUJIFILM / Forum for Innovative Regenerative Medicine, on loan
Dec. 2017Manager, Healthcare Business Development Office, FUJIFILM
Mar. 2018Director, Perseus Proteomics Inc. (the Company)
Jun. 2018President & CEO, the Company (to present)
Jan. 2019Executive Officer, the Company (to present)


(Date of birth: Sep. 20, 1955)


Apr. 1978Joined Kokusai Denshin Denwa Co. Ltd. (currently KDDI CORPORATION)
Jul. 1996Vice President, KDD Europe (currently KDDI Europe)
Feb. 2002President, Telehouse Europe
Apr. 2005Network Solution KANSAI Regional Office, KDDI CORPORATION (KDDI)
Apr. 2008Regional Executive Officer, Asia Pacific/President, KDDI Singapore
Jan. 2010Vice Chairman, DMX Technologies Group LTD
Jan. 2013Executive Director, Global ICT Business Division, Global Business Sector, KDDI
Jun. 2016Statutory Auditor, KDDI Evolva, Inc.
Sep. 2018Outside Director, ACSL Ltd.
Jun. 2019Statutory Auditor, the Company
Jun. 2020Director, Executive Officer & Head of Administrative Dept.,the Company (to present)


(Date of birth: Jan. 28, 1959)


Apr. 1988Assistant, School of Medicine, Shinshu University
Oct. 1992Research Associate, Dartmouth Medical School
Oct. 1997Researcher, Institute of Biotechnology and Industrial Technology,
Agency of Industrial Science and Technology, Ministry of Trade and Industry (currently Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, National Research and Development Agency)
Apr. 2002Joined HuBit genomix Co., Ltd. (HuBit)
Apr. 2003Manager, Research and Development Dept., HuBit
May. 2005Joined the Company
Feb. 2009Head of Research and Development Dept., the Company
Jan. 2019Executive Officer & Head of Research and Development Dept., the Company
Jun. 2019Director, the Company (to present)
Jun. 2022Executive Officer & CTO, the Company (to present)

Kinichiro KOMINAMI

(Date of birth: Jan. 20, 1967)


Jul. 1994PhD, Researcher, Imperial Cancer Research Fund Laboratories
Sep. 1998Assistant Professor, Medical Institute of Bioregulation, Kyushu University
Jun. 2001Joined Nomura Securities, Co., Ltd. (Nomura Securities)
Nomura Research and Advisory Co., Ltd. (NRA) on loan
Jun. 2011Executive Director, Investment Dept. NRA
Apr. 2013 Section Chief, Regional Financial Institutional and Public Sector Clients Consulting Dept., Nomura Securities
Aug. 2015Director, Corporate Business Group, Mizuho Securities, Co., Ltd.
Sep. 2017President & CEO, Tech & FinStrategy Inc. (to present)
Oct. 2017Outside Director, Cellspect Co., Ltd. (to present)
Jun. 2018Director, the Company (to present)
Outside Director, Delta-Fly Pharma, Inc. (to present)
Aug. 2019Outside Director, Veritas In Silico Inc. (to present)
Aug. 2021Outside Director, EGAIA Co., Ltd. (to present)
Dec. 2021Outside Director, RMiC : Regenerative Medicine iPS Gateway Center Co., Ltd. (currently Repli-tech Co., Ltd.) (to present)
Feb. 2022Director, TransMed, Inc. (to present)


(Date of birth: Apr. 30, 1953)


Apr. 1976Joined Kyowa Hakko Kogyo Co., Ltd.
Feb. 2003President, BioWa, Inc.
Jun. 2006Executive Officer, Kyowa Hakko Kogyo Co., Ltd.
Oct. 2008Operating Director & Head of Development Dept., Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.)
Apr. 2009Managing Executive Officer & Head of Development Dept., Kyowa Kirin Co., Ltd. (Kyowa Kirin)
Jun. 2009Director & Senior Managing Executive Officer, Kyowa Kirin
Mar. 2010Director & Executive Operating Officer, Kyowa Kirin
Mar. 2012Executive Director, President & CEO, Kyowa Kirin
Mar. 2018Executive Director, Chairman & CEO, Kyowa Kirin
Mar. 2019Director & Chairman, Kyowa Kirin
May. 2020Director, Leave a Nest Co., Ltd. (to present)
Jun. 2020Outside Director, Shimadzu Corp. (to present)
Mar. 2021Director, the Company (to present)
Jun. 2021Outside Director, Aculys Pharma, Inc. (to present)

Director, Audit & Supervisory Committee Member


Tatsuya NAGASE

(Date of birth: Dec. 7, 1956)


Apr. 1981Joined Kokusai Denshin Denwa Co., Ltd (currently KDDI CORPORATION)
Sep. 2000Managing Director, KDDI Australia Pty Ltd
Apr. 2010Internal Control Manager, Risk Management HQ, KDDI CORPORATION
Jul. 2011Full-time Audit & Supervisory Board Member, Evolva Business Support, Inc. (currently KDDI Evolva, Inc.)
Jul. 2013Full-time Audit & Supervisory Board Member, KDDI Evolva Call Advance, Inc. (currently KDDI Evolva, Inc.)
Apr. 2017Audit & Supervisory Board Member, ARISE analytics Inc.
Jun. 2017Audit & Supervisory Board Member, Japan Internet Exchange Co., Ltd.
Aug. 2017Audit & Supervisory Board Member, SORACOM, INC.
Jul. 2019Full-time Audit & Supervisory Board Member, CREEMA LTD.
Oct. 2019Outside Audit & Supervisory Board Member, Japaniace Co., Ltd. (to present)
May 2020Full-time Outside Audit & Supervisory Board Member, GEOCODE CO.,Ltd.
Jun. 2022Director, Audit & Supervisory Committee Member, the Company (to present)


(Date of birth: Sep. 26, 1946)


Apr. 1972Joined Daiichi Pharmaceutical Co., Ltd (currently Daiichi Sankyo Co., Ltd.)
Apr. 1989Senior Researcher, Molecular Biology Laboratory, Daiichi Sankyo Co., Ltd. (Daiichi)
Oct. 1996General Manager, Drug Discovery Research Laboratory, Daiichi
Oct. 1999Corporate Officer & General Manager, Drug Discovery Research Laboratory, Daiichi
Apr. 2007 Standing Statutory Auditor, Asubio Pharma Co., Ltd. (currently Daiichi Sankyo Co., Ltd.)
Jul. 2008Senior Coodinator, Center for Research Promotion, Comprehensive Research Promotion Organization, Keio University
Apr. 2016Guest Professor, Clinical & Translational Research Center, School of Medicine, Keio University (to present)
Sep. 2017Science and Technical Advisor, Japan Agency for Medical Research and Development
Jun. 2019Statutory Auditor, the Company
Jun. 2020Director, Audit & Supervisory Committee Member, the Company (to present)

Takashi OHNO

(Date of birth: Dec. 14, 1969)


Mar. 1996Joined Showa Ota & Co. (currently Ernst & Young ShinNihon LLC)
Oct. 1998Joined Asahi & Co. (currently KPMG AZSA LLC)
Apr. 2000Registered as Certified Public Accountant
Apr. 2002Registered as Certified Public Tax Accountant
Jan. 2006Joined Ichiyoshi Securities Co., Ltd.
Feb. 2010Joined CMIC Co., Ltd. (currently CMIC HOLDINGS Co., Ltd.)
Oct. 2016Representative, Ohno Certified Public Accountant’s Office (to present)
Jun. 2021Director, Audit & Supervisory Committee Member, the Company (to present)
Sep. 2021Representative Partner, Mita-Kaikeisha Tax Co. (to present)